Clinical Trial: CAR-T Therapy: Safety, Efficacy, and Immune-Escape Mechanisms

U.S., Nov. 5 -- ClinicalTrials.gov registry received information related to the study (NCT07915102) titled 'CAR-T Therapy: Safety, Efficacy, and Immune-Escape Mechanisms' on Oct. 19.

Brief Summary: The study is a biological, drug-related, non-interventional observational study with both retrospective and prospective components.

No experimental diagnostic procedures, investigational medicinal products, or medical devices will be used, and samples will be collected as part of routine clinical practice.

Study Start Date: Feb. 02, 2023

Study Type: OBSERVATIONAL

Condition: CAR-T Cell Therapy Bispecific Antibodies

Recruitment Status: RECRUITING

Sponsor: Ciceri Fabio

Information provided by (Responsible Party): Ciceri Fabio, IRCCS San Raf...